Patents by Inventor Raymond E. STEVENS

Raymond E. STEVENS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solabegron zwitterion and uses thereof
    Patent number: 12435026
    Abstract: This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.
    Type: Grant
    Filed: May 18, 2023
    Date of Patent: October 7, 2025
    Assignee: B3AR THERAPEUTICS, INC.
    Inventors: Raymond E. Stevens, Dalian Zhao, Bingidimi Itute Mobele
  • SOLABEGRON ZWITTERION AND USES THEREOF
    Publication number: 20240124391
    Abstract: This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.
    Type: Application
    Filed: May 18, 2023
    Publication date: April 18, 2024
    Applicant: B3AR THERAPEUTICS, INC.
    Inventors: Raymond E. STEVENS, Dalian ZHAO, Bingidimi Itute MOBELE
  • Solabegron zwitterion and uses thereof
    Patent number: 11691944
    Abstract: This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.
    Type: Grant
    Filed: October 22, 2020
    Date of Patent: July 4, 2023
    Assignee: B3AR THERAPEUTICS, INC.
    Inventors: Raymond E. Stevens, Dalian Zhao, Bingidimi Itute Mobele
  • SOLABEGRON ZWITTERION AND USES THEREOF
    Publication number: 20210317073
    Abstract: This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.
    Type: Application
    Filed: October 22, 2020
    Publication date: October 14, 2021
    Inventors: Raymond E. STEVENS, Dalian ZHAO, Bingidimi Itute MOBELE
  • Solabegron zwitterion and uses thereof
    Patent number: 10844004
    Abstract: This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.
    Type: Grant
    Filed: January 11, 2019
    Date of Patent: November 24, 2020
    Assignee: Velicept Therapeutics, Inc.
    Inventors: Raymond E. Stevens, Dalian Zhao, Bingidimi Itute Mobele
  • SOLABEGRON ZWITTERION AND USES THEREOF
    Publication number: 20190185414
    Abstract: This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.
    Type: Application
    Filed: January 11, 2019
    Publication date: June 20, 2019
    Inventors: Raymond E. STEVENS, Dalian ZHAO, Bingidimi Itute MOBELE
  • Solabegron zwitterion and uses thereof
    Patent number: 10221126
    Abstract: This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: March 5, 2019
    Assignee: VELICEPT THERAPEUTICS, INC.
    Inventors: Raymond E. Stevens, Dalian Zhao, Bingidimi Itute Mobele
  • SOLABEGRON ZWITTERION AND USES THEREOF
    Publication number: 20180370902
    Abstract: This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.
    Type: Application
    Filed: June 26, 2018
    Publication date: December 27, 2018
    Inventors: Raymond E. STEVENS, Dalian ZHAO, Bingidimi Itute MOBELE
  • Solabegron zwitterion and uses thereof
    Patent number: 10065922
    Abstract: This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.
    Type: Grant
    Filed: October 24, 2016
    Date of Patent: September 4, 2018
    Assignee: Velicept Therapeutics, Inc.
    Inventors: Raymond E. Stevens, Dalian Zhao, Bingidimi Itute Mobele
  • Solabegron Zwitterion and Uses Thereof
    Publication number: 20170114005
    Abstract: This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This application also relates to methods of preparing solabegron hydrochloride from the solabegron zwitterion.
    Type: Application
    Filed: October 24, 2016
    Publication date: April 27, 2017
    Inventors: Raymond E. STEVENS, Dalian ZHAO, Bingidimi Itute MOBELE